JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2326
CALL
Ecolab
ECL
$78.7B
| $6.67M | ﹤0.01% |
34,700
| – | – |
2018 Q2
4 quarters
|
|
|
BFIN
2327
DELISTED
BankFinancial
BFIN
| $6.67M | ﹤0.01% |
482,247
+48,282
| +11% | +$701K |
2013 Q2
24 quarters
|
|
|
NBL
2328
DELISTED
Noble Energy, Inc.
NBL
| $6.66M | ﹤0.01% |
305,356
+9,022
| +3% | +$214K |
2013 Q2
24 quarters
|
|
2329
ZTO Express
ZTO
$14.7B
| $6.65M | ﹤0.01% |
346,393
-565,397
| -62% | -$10.6M |
2016 Q4
10 quarters
|
|
2330
Signet Jewelers
SIG
$3.91B
| $6.65M | ﹤0.01% |
375,925
+195,390
| +108% | +$4.2M |
2013 Q2
24 quarters
|
|
2331
Columbus McKinnon
CMCO
$491M
| $6.63M | ﹤0.01% |
161,162
+2,801
| +2% | +$107K |
2013 Q2
24 quarters
|
|
2332
PUT
Kroger
KR
$34.5B
| $6.63M | ﹤0.01% |
310,000
| – | – |
2017 Q3
7 quarters
|
|
|
KBAL
2333
DELISTED
Kimball International
KBAL
| $6.58M | ﹤0.01% |
388,298
+191,209
| +97% | +$3.02M |
2013 Q2
24 quarters
|
|
2334
State Street Blackstone Senior Loan ETF
SRLN
$5.5B
| $6.58M | ﹤0.01% |
142,216
-30,840
| -18% | -$1.43M |
2013 Q2
24 quarters
|
|
2335
PUT
Enterprise Products Partners
EPD
$80.5B
| $6.58M | ﹤0.01% |
229,800
+79,800
| +53% | +$2.3M |
2019 Q1
1 quarter
|
|
2336
PUT
TJX Companies
TJX
$151B
| $6.56M | ﹤0.01% |
124,100
+69,100
| +126% | +$3.67M |
2018 Q3
3 quarters
|
|
2337
CALL
Sanofi
SNY
$94.8B
| $6.56M | ﹤0.01% |
152,200
+60,000
| +65% | +$2.55M |
2019 Q1
1 quarter
|
|
|
2338
PUT
Sanofi
SNY
$94.8B
| $6.56M | ﹤0.01% |
152,200
+60,000
| +65% | +$2.55M |
2019 Q1
1 quarter
|
|
2339
Vanguard Extended Market ETF
VXF
$30.8B
| $6.53M | ﹤0.01% |
55,713
-293
| -0.5% | -$34.2K |
2013 Q2
24 quarters
|
|
|
SFIX
2340
Stitch Fix
SFIX
$357M
| $6.52M | ﹤0.01% |
214,252
+92,963
| +77% | +$2.49M |
2018 Q2
4 quarters
|
|
|
VRN
2341
DELISTED
Veren
VRN
| $6.51M | ﹤0.01% |
1,966,569
+625,987
| +47% | +$2.25M |
2014 Q1
21 quarters
|
|
2342
Crocs
CROX
$5.76B
| $6.51M | ﹤0.01% |
331,677
-136,143
| -29% | -$3.15M |
2013 Q2
24 quarters
|
|
|
BPMC
2343
PUT
DELISTED
Blueprint Medicines
BPMC
| $6.49M | ﹤0.01% |
+70,000
| New | +$5.78M |
2019 Q2
0 quarters
|
|
2344
B2Gold
BTG
$6.88B
| $6.49M | ﹤0.01% |
2,183,950
+1,597,044
| +272% | +$4.37M |
2013 Q2
24 quarters
|
|
|
2345
PUT
Occidental Petroleum
OXY
$58.3B
| $6.47M | ﹤0.01% |
130,000
+100,000
| +333% | +$5.63M |
2016 Q4
10 quarters
|
|
2346
WisdomTree US LargeCap Dividend Fund
DLN
$6.24B
| $6.45M | ﹤0.01% |
134,028
+14,730
| +12% | +$703K |
2015 Q4
14 quarters
|
|
2347
HealthStream
HSTM
$958M
| $6.45M | ﹤0.01% |
247,694
+113,684
| +85% | +$2.99M |
2017 Q3
7 quarters
|
|
2348
Pediatrix Medical
MD
$2.11B
| $6.45M | ﹤0.01% |
262,102
-19,374
| -7% | -$520K |
2013 Q2
24 quarters
|
|
|
EPZM
2349
DELISTED
Epizyme, Inc
EPZM
| $6.45M | ﹤0.01% |
528,411
+79,251
| +18% | +$1.02M |
2014 Q1
21 quarters
|
|
2350
ICL Group
ICL
$6.56B
| $6.44M | ﹤0.01% |
1,240,956
-724,158
| -37% | -$3.83M |
2014 Q3
19 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.